HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment with aliskiren ameliorates tacrolimus-induced nephrotoxicity in rats.

AbstractINTRODUCTION:
Tacrolimus is frequently used as immunosuppressive agent in organ transplantation but its clinical use is limited due to its marked nephrotoxicity.
MATERIALS AND METHODS:
Male Wistar albino rats weighing 150-200 g (10-12 weeks old) were used. Animals were divided into four groups. Group 1 served as control group and received normal saline, group 2 served as toxic group and received 2 mg/kg tacrolimus i.p., group 3 served as treatment group and received 2 mg/kg tacrolimus i.p. followed by 2 mg/kg aliskiren orally and group 4 served as drug per se group and received 2 mg/kg aliskiren orally. Tacrolimus-induced nephrotoxicity was assessed biochemically and histopathologically.
RESULTS:
Treatment with aliskiren decreased the tacrolimus-induced changes in biochemical markers of nephrotoxicity such as blood urea nitrogen and creatinine. Aliskiren also attenuated the effects of tacrolimus on oxidative stress parameters such as malondialdehyde, reduced glutathione and catalase. Histopathological and ultrastructural studies showed that aliskiren attenuated tacrolimus-induced renal damage.
CONCLUSION:
These results suggest that aliskiren has protective effects against tacrolimus-induced nephrotoxicity; implying that renin inhibitor may counteract nephrotic syndrome associated with immunosuppressant use.
AuthorsNaif O Al-Harbi, Faisal Imam, Mohammed M Al-Harbi, Muzaffar Iqbal, Ahmed Nadeem, Othman A Al-Shahrah, Hesham M Korashy, Khalid A Al-Hosaini, Mukhtar Ahmed, Saleh Bahashwar
JournalJournal of the renin-angiotensin-aldosterone system : JRAAS (J Renin Angiotensin Aldosterone Syst) Vol. 16 Issue 4 Pg. 1329-36 (Dec 2015) ISSN: 1752-8976 [Electronic] England
PMID24737642 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2014.
Chemical References
  • Amides
  • Fumarates
  • aliskiren
  • Catalase
  • Glutathione
  • Tacrolimus
Topics
  • Amides (pharmacology, therapeutic use)
  • Animals
  • Catalase (metabolism)
  • Fumarates (pharmacology, therapeutic use)
  • Glutathione (metabolism)
  • Kidney (drug effects, pathology, physiopathology, ultrastructure)
  • Kidney Diseases (blood, chemically induced, drug therapy, physiopathology)
  • Lipid Peroxidation (drug effects)
  • Male
  • Oxidative Stress (drug effects)
  • Rats, Wistar
  • Tacrolimus (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: